Literature DB >> 31869256

The role of cardiopulmonary exercise testing and training in patients with pulmonary hypertension: making the case for this assessment and intervention to be considered a standard of care.

Ahmad Sabbahi1,2,3, Richard Severin1,4, Cemal Ozemek1, Shane A Phillips1, Ross Arena1.   

Abstract

Introduction: Pulmonary hypertension (PH) is a broad pathophysiological disorder primarily characterized by increased pulmonary vascular resistance due to multiple possible etiologies. Patients typically present with multiple complaints that worsen as disease severity increases. Although initially discouraged due to safety concerns, exercise interventions for patients with PH have gained wide interest and multiple investigations have established the effective role of exercise training in improving the clinical profile, exercise tolerance, and overall quality of life.Areas covered: In this review, we discuss the pathophysiology of PH during rest and exercise, the role of cardiopulmonary exercise testing (CPX) in the diagnosis and prognosis of PAH, the role of exercise interventions in this patient population, and the expected physiological adaptations to exercise training.Expert opinion: Exercise testing, in particular CPX, provides a wealth of clinically valuable information in the PH population. Moreover, the available evidence strongly supports the safety and efficacy of exercise training as a clinical tool in improving exercise tolerance and quality of life. Although clinical trials investigating the role of exercise in this PH population are relatively few compared to other chronic conditions, current available evidence supports the clinical implementation of exercise training as a safe and effective treatment modality.

Entities:  

Keywords:  Exercise; cardiopulmonary exercise testing; pulmonary hypertension

Year:  2020        PMID: 31869256      PMCID: PMC7265169          DOI: 10.1080/17476348.2020.1708196

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  74 in total

1.  The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.

Authors:  Stephen C Mathai; Milo A Puhan; Diana Lam; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

Review 2.  Pulmonary Hypertension and Exercise.

Authors:  James R Vallerand; Jason Weatherald; Pierantonio Laveneziana
Journal:  Clin Chest Med       Date:  2019-06       Impact factor: 2.878

3.  Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension.

Authors:  Benjamin D Fox; Michael Kassirer; Israela Weiss; Yael Raviv; Nir Peled; David Shitrit; Mordechai R Kramer
Journal:  J Card Fail       Date:  2010-12-03       Impact factor: 5.712

Review 4.  Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives.

Authors:  A M Marra; M Arcopinto; E Bossone; N Ehlken; A Cittadini; E Grünig
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-10-19       Impact factor: 4.222

5.  Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension.

Authors:  Robin Condliffe; David G Kiely; J Simon R Gibbs; Paul A Corris; Andrew J Peacock; David P Jenkins; Denise Hodgkins; Kim Goldsmith; Rodney J Hughes; Karen Sheares; Steven S L Tsui; Iain J Armstrong; Chantal Torpy; Rachel Crackett; Christopher M Carlin; Clare Das; J Gerry Coghlan; Joanna Pepke-Zaba
Journal:  Am J Respir Crit Care Med       Date:  2008-02-21       Impact factor: 21.405

6.  Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension.

Authors:  Ali A Weinstein; Lisa M K Chin; Randall E Keyser; Michelle Kennedy; Steven D Nathan; Joshua G Woolstenhulme; Gerilynn Connors; Leighton Chan
Journal:  Respir Med       Date:  2013-03-07       Impact factor: 3.415

7.  Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension.

Authors:  M Nootens; C J Wolfkiel; E V Chomka; S Rich
Journal:  Am J Cardiol       Date:  1995-02-15       Impact factor: 2.778

Review 8.  Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains.

Authors:  Miranda K Culley; Stephen Y Chan
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

9.  Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension.

Authors:  Vincent Mainguy; François Maltais; Didier Saey; Philippe Gagnon; Simon Martel; Mathieu Simon; Steeve Provencher
Journal:  Thorax       Date:  2009-08-30       Impact factor: 9.139

10.  Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension.

Authors:  Yi-Jen Chen; Hung-Pin Tu; Chia-Ling Lee; Wei-Chun Huang; Jin-Shiou Yang; Cyuan-Fong Li; Chia-Hsin Chen; Ko-Long Lin
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.